Our Mission

BIOMUNEX Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of breakthrough immunotherapies using its Unique BiXAb® technology to create next generation bi- and multi-specific antibodies.

Next Generation Bi- and Multi-specific Antibodies for disruptive biological approaches

Our disruptive biological approaches target a number of cancer types, in particular where there are unmet medical needs. We are committed to provide oncologists and patients with immunotherapies that are novel, efficacious and prolong life expectancy.

[saturnthemes_industry_icon_button btn_align= »center » icon_fontawesome= »fa fa-share » btn_size= »btn-normal-size » link= »url:http%3A%2F%2Fwww.biomunex.com%2Fabout-us%2F|title:Readmore|target:%20_blank| » css= ».vc_custom_1506178545598{margin-bottom: 20px !important;} »]

Technologies & Products

CANCER AND BISPECIFIC ANTIBODY THERAPIES

BIOMUNEX BiXAb® PLATFORM

Pipeline

[saturnthemes_industry_icon_box icon_fontawesome= »fa fa-envelope-o » box_bg_color= »rgba(0,0,0,0.5) » box_style= » » title= »Contact Us » title_color= »rgba(255,255,255,0.4) » content_color= »#ffffff » icon_background_color= »rgba(0,0,0,0.4) »]14 avenue d’Eylau
75116 PARIS[/saturnthemes_industry_icon_box]
[saturnthemes_industry_icon_box icon_fontawesome= »fa fa-envelope-o » box_bg_color= »rgba(0,0,0,0.5) » box_style= » » title= »Email Us » title_color= »rgba(255,255,255,0.4) » content_color= »#ffffff » icon_background_color= »rgba(0,0,0,0.4) »]contact@biomunex.com[/saturnthemes_industry_icon_box]